|
Impella cp was inserted percutaneously via right femoral artery access site in an 73-year-old female patient presenting with high-risk percutaneous coronary intervention (hrpci).The patient¿s comorbidities included known coronary artery disease (cad) and diabetes mellitus.The patient¿s clinical state prior to initiation of support was society for cardiovascular angiography and interventions (scai) shock stage c.The patient was medically supported by inotropes, vasopressors.During support, the ao placement signal was observed at 98/70 mmhg and suddenly increased to 223/99 mmhg with a corresponding left ventricular placement signal increase to 235/38 mmhg.No changes were noted in pump performance, motor current, purge flow, purge pressure, or flow rate, which remained at 3.3 l/min at performance(p) p8.The clinical support center (csc) was contacted and recommended echocardiographic evaluation to confirm device position and indicated suspicion of an optical sensor failure.Subsequently, the patient developed acute right-sided weakness and slurred speech, prompting a stroke alert.Neurological evaluation documented an national institutes of health (nih) stroke scale score of 9 (classified as a moderate stroke) with diffuse but right-sided predominant weakness and dysarthria.Computed tomography of the head was negative for hemorrhage, while ct angiography demonstrated multivessel stenosis without large vessel occlusion.The treating team reported the event appeared embolic in nature and most likely cardioembolic in the setting of non-st segment elevation myocardial infarction (nstemi), with possible infarction of the left pyramidal tract pending mri evaluation.The patient remained on maximum medical therapy including heparin, aspirin, and ticagrelor.Pump position was subsequently confirmed by echocardiography, and no device replacement or removal due to the reported signal issue was required.The patient was successfully weaned from support, the device was explanted without complication, and the patient survived.A causal relationship between the impella device and the patient¿s stroke could not be dissociated based on the information provided.
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by abiomed inc, or its employees that the report constitutes an admission that the product, abiomed inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|